Safety and Tolerability Study of Single-dose Administration of Brexpiprazole in Adult Subjects With Schizophrenia
Clinical trial NCT02968121 · TERMINATED
Trial details
- NCT number
- NCT02968121
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2017-12-14
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.